NCT00511186 - A Study in Sepsis Patients With Renal Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

SepsisBacterial Infections and Mycoses

Interventions

DRUG

Placebo

placebo is administered intravenously over 48 hours. An initial loading dose of over 10-minutes is followed by continuous infusion over 48h.

DRUG

BIAP

AP is administered intravenously over 48 hours. An initial loading dose of 67.5U/Kg body weight over 10-minutes is followed by continuous infusion of 132.5U/Kg/24H administered over 48H

Trial Locations (9)

Unknown

University Medical Center Antwerp (UZA), Antwerp

Cliniques Universitaires Saint Luc-UCL, Brussels

ULB Hopital Erasme, Brussels

Universitair Ziekenhuis Brussel, Brussels

Jeroen Bosch Ziekenhuis lokatie GZG, 's-Hertogenbosch

VU University Medical Center, Amsterdam

Canisius Wilhelmina Ziekenhuis, Nijmegen

6500 HB

UMC Nijmegen University Medical Center St Radboud, Nijmegen

8011 JW

Isala Clinics, Zwolle